| Literature DB >> 31741591 |
Anna Varghese1, Shyamkumar N Keshava1, Vinu Moses1, George Koshy1, Suraj Mammen1, Munawwar Ahmed1, Roshan S Livingstone1.
Abstract
BACKGROUND: Fluoroscopy-guided interventions can potentially increase radiation risk to patients, if awareness on angiographic imaging technique and radiation dose is neglected. AIM: To develop patient radiation dose reference card from standardized imaging techniques for various radiology interventions performed using flat detector based angiography system.Entities:
Keywords: Flat detector; interventional radiology; radiation dose reference card
Year: 2019 PMID: 31741591 PMCID: PMC6857258 DOI: 10.4103/ijri.IJRI_35_19
Source DB: PubMed Journal: Indian J Radiol Imaging ISSN: 0970-2016
Exposure factors for radiological interventions from Siemens Artis Zee biplane angiography system
| Radiological interventions | Fluoroscopic screening | Image acquisitions | ||||
|---|---|---|---|---|---|---|
| Mean kVp (range) | Mean mA (range) | fps (Cu mm) | Mean kVp (range) | Mean mA (range) | Mean No. of image acquisitions (range) | |
| Adults | ||||||
| Sclerotherapy# | 68 (66-71) | 97 (13-220) | - | - | - | - |
| Cerebral angiography | 66 (65-69) | 93 (81-200) | 4, 30 (0.1-0.3) | 70 (69-75) | 301 (283-361) | 9.8 (4-20) |
| Cerebral embolization | 67 (65-69) | 124 (91-194) | 4, 30 (0.1-0.3) | 74 (71-84) | 286 (273-307) | 21.1 (8-48) |
| BAE | 67 (66-68) | 124 (94-189) | 4 (0.1-0.3) | 67 (63-70) | 378 (323-407) | 13.9 (5-26) |
| Abdominal angiography* | 66 (65-68) | 124 (105-148) | 4 (0.1-0.3) | 69 (67-70) | 390 (288-576) | 8.8 (3-14) |
| Abdominal embolization | 67 (65-70) | 136 (98-198) | 4 (0.1-0.3) | 73 (66-86) | 371 (272-493) | 13.3 (3-23) |
| TJLB | 65 (65-68) | 127 (93-217) | 4, 5, 7.5 (0.1-0.3) | 74 (67-81) | 331 (173-383) | 1.2 (1-2) |
| TACE | 67 (66-69) | 149 (118-209) | 4 (0.1-0.3) | 70 (66-74) | 376 (280-571) | 7.8 (3-16) |
| IVC Plasty | 65 (65-70) | 128 (98-209) | 4 (0.1-0.3) | 72 (70-76) | 396 (335-556) | 8.8 (3-20) |
| TIPSS* | 67 (65-69) | 162 (140-183) | 4, 7.5 (0.1-0.3) | 75 (73-79) | 342 (321-352) | 10.6 (7-16) |
| DIPSS* | 66 (65-68) | 115 (97-134) | 4 (0.1-0.3) | 70 (69-71) | 382 (380-384) | 11.3 (9-14) |
| PTBD | 65 (65-67) | 129 (89-210) | 1,4 (0.1-0.3) | 71 (66-83) | 398 (363-428) | 2.5 (1-8) |
| PCN | 65 (65-67) | 110 (92-225) | 1, 4 (0.1-0.3) | 72 (67-85) | 332 (220-356) | 1.2 (1-2) |
| Spinal angiography* | 66 (65-68) | 141 (92-203) | 4 (0.1-0.3) | 72 (68-74) | 453 (346-599) | 28.4 (12-43) |
| Peripheral venogram * | 66 (65-68) | 112 (94-145) | 4 (0.1-0.3) | 76 (66-97) | 338 (232-399) | 3.3 (2-5) |
| Peripheral embolization* | 66 (65-68) | 80 (19-200) | 4 (0.1-0.3) | 65 (61-73) | 199 (131-404) | 8.6 (2-22) |
| Paediatrics | ||||||
| Sclerotherapy# (extremities) | 67.2 (66-71) | 50.3 (10.2-142.7) | - | - | - | - |
| Sclerotherapy# (face, neck, and tongue) | 67.4 (66-71) | 105.6 (38.6-170) | - | - | - | - |
| Cerebral angiography* | 65.1 (65-66) | 87.6 (83.5-95.9) | 4 (0.1-0.3) | 70 (69-71) | 319.6 (292.8-381) | 11.5 (6-18) |
| TJLB* | 65 | 95.2 (95.1-97.6) | 7.5 (0.3) | 76 | 165.3 (144-177) | 1.7 (1-2) |
| Abdominal Embolization* | 69 (67.7-68) | 95.3 (85.1-110.1) | 4 (0.3) | 67 (66-70) | 420 (392-475) | 12.6 (6-25) |
| Peripheral embolization* | 66 | 84.5 (72.4-96.5) | 4 (0.3) | 66 | 151 (150-152) | 13.5 (5-22) |
BAE: Bronchial artery embolization; TJLB: Transjugular liver biopsy; TACE: Transarterial chemoembolization; IVC: Inferior vena cava; TIPSS: Trans intrahepatic portosystemic shunt; DIPSS: Direct intrahepatic portosystemic shunt; PTBD: Percutaneous transhepatic biliary drainage; PCN: Percutaneous nephrostomy; pps: Pulse per second; fps: Frames per second; Cu: Copper filter; #DSA image acquisitions were not performed; *Interventions with sample size <10
Radiation dose reference card for interventional radiological procedures
| Radiological interventions | Mean FT in min (range) | Mean DAP in Gycm2 (range) | Mean Ka, r in Gy (range) | Mean ED (mSv) | Equivalent period of exposure to natural background radiation (3 mSv) | Level of risk |
|---|---|---|---|---|---|---|
| Adults | ||||||
| Sclerotherapy# | 1.2 (0.2-2.4) | 0.6 (0.02-5.2) | 0.005 (0-0.03) | - | - | - |
| Cerebral angiography | 5.1 (0.8-23.9) | 47.6 (18.2-100.3) | 0.4 (0.1-0.7) | 3.3 | 1 year | Low |
| Cerebral embolization | 38.4 (17.3-83.4) | 111.1 (57.4-161.7) | 1.5 (0.5-2.8) | 6.8 | 2 years | Low |
| BAE | 27.2 (5.7-51.7) | 26.8 (2.2-65.2) | 0.3 (0.02-0.8) | 10.6 | 4 years | Low |
| Abdominal angiography* | 12.4 (0.8-27.8) | 47.0 (31.9-57.9) | 0.3 (0.1-0.4) | 7.4 | 2 years | Low |
| Abdominal embolization | 22.7 (4.2-52.9) | 69.0 (5.3-154.6) | 0.7 (0.07-1.4) | 14.9 | 5 years | Low |
| TJLB | 5.3 (1.7-10.8) | 5.2 (0.82-11.3) | 0.06 (0.006-0.1) | 1.9 | 1 year | Low |
| TACE | 20.3 (8.5-42.6) | 43.7 (8.5-94.8) | 0.5 (0.1-1.0) | 28.6 | 10 years | Moderate |
| IVC Plasty | 14.8 (1.8-31.9) | 30.4 (9.4-54.6) | 0.4 (0.1-0.8) | 9.9 | 3 years | Low |
| TIPSS* | 46.8 (23.9-90.8) | 96.0 (40.1-176.4) | 0.8 (0.3-1.5) | 26.4 | 9 years | Low |
| DIPSS* | 27.8 (19.7-37.0) | 53.3 (40.4-63.7) | 0.4 (0.4-0.5) | 13.7 | 5 years | Low |
| PTBD | 5.3 (0.3-20.6) | 4.4 (0.2-23.0) | 0.08 (0.002-0.005) | 1.9 | 1 year | Very low |
| PCN | 1.3 (0.1 -7.5) | 2.3 (0.2-5.7) | 0.03 (0.002-0.1) | 0.3 | 0.1 year | Very low |
| Spinal angiography* | 17.5 (10.4-33.2) | 186.7 (44.0-377.5) | 1.4 (0.5-2.7) | 59.4 | 20 years | Moderate |
| Peripheral venogram#* | 5.7 (0.4-13.9) | 12.6 (5.3-25.3) | 0.1 (0.06-0.3) | - | - | - |
| Peripheral embolization#* | 5.5 (0.5-10.6) | 11.2 (0.1-52.3) | 0.09 (0.0007-0.5) | - | - | - |
| Paediatrics | ||||||
| Sclerotherapy# (extremities) | 1.2 (0-2.3) | 0.21 (0.03-1.8) | 0.001 (0-0.008) | - | - | - |
| Sclerotherapy# (face, neck, and tongue) | 1.1 (0.5-2.4) | 0.5 (0.11-2.1) | 0.007 (0.002-0.02) | - | - | - |
| Cerebral angiography* | 3.4 (2.0-6.1) | 29.9 (14.8-63.3) | 0.2 (0.1-0.5) | 2.8 | 1 year | Low |
| TJLB* | 3.0 (1.6-5.2) | 0.9 (0.5-1.9) | 0.01 (0.007-0.03) | 0.4 | 0.1 year | Very low |
| Abdominal embolization* | 17.7 (10.0-25.6) | 16.3 (4.9-35.1) | 0.2 (0.08-0.6) | 12.7 | 4 years | Low |
BAE: Bronchial artery embolization; TJLB: Transjugular liver biopsy; TACE: Transarterial chemoembolization; IVC: Inferior vena cava; TIPSS: Trans intrahepatic portosystemic shunt; DIPSS: Direct intrahepatic portosystemic shunt; PTBD: Percutaneous transhepatic biliary drainage; PCN: Percutaneous nephrostomy; FT: Fluoroscopy time; DAP: Dose area product; Ka: r: Reference air kerma; ED: Effective dose; #ED were not estimated for extremities in PCXMC; *Interventions with sample size <10
| Risk level | Negligible | Minimal | Very low | Low | Moderate |
|---|---|---|---|---|---|
| Estimated additional risk of developing fatal cancer | < 1 in 1,000,000 | 1 in 1,000,000 to 1 in 100,000 | 1 in 100,000 to 1 in 10,000 | 1 in 10,000 to 1 in 1000 | 1 in 1000 to 1 in 500 |